21 Sept, 2011
1. Lupin :-
Current Market Price - 487.80
Target - 498
Lupin got US FDA approval for Oral Contraceptive Norethindrone. Pharma stocks have so far not participated in the market rally, and good participation is anticipated with positive news on this approval for Lupin.
2. HDIL :-
Current Market Price - 113.00
Target - 118.00
HDIL is selling 5 Million Sq. ft.in Virar, North Mumbai to reduce debt. It has already sold 1 Million Sq ft to a local builder. This move will improve Firms Financial health and Money raising capabilities.
However, the outlook of real estate sector on markets is still very bleak. We thus suggest selling the stock on every rise.
No comments:
Post a Comment